carvedilol has been researched along with nicorandil in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Cockcroft, JR; Mason, RP | 1 |
| Abdallah, H; Abdel Maksoud, OM; Bastawy, N; Ibrahim, W; Morsi, H; Rashed, LA; Soliman, GF | 1 |
1 review(s) available for carvedilol and nicorandil
| Article | Year |
|---|---|
Targeting nitric oxide with drug therapy.
Topics: Adrenergic alpha-Antagonists; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzopyrans; Biological Availability; Calcium Channel Blockers; Carbazoles; Carvedilol; Ethanolamines; Heart Diseases; Humans; Isosorbide Dinitrate; Nebivolol; Neurodegenerative Diseases; Nicorandil; Nitrates; Nitric Oxide; Nitric Oxide Donors; Propanolamines; Vasodilator Agents | 2006 |
3 other study(ies) available for carvedilol and nicorandil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Interrelation of liver vascularity to non-alcoholic fatty liver through a comparative study of the vasodilator effect of carvedilol or nicorandil in rats.
Topics: Adrenergic beta-Antagonists; Animals; Carvedilol; Liver; Male; Nicorandil; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 2019 |